SCHEMBL22014897

SCHEMBL22014897

CC(=O)Cc1c(C(C)C)cc(F)cc1C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 5/20 0.41
GAA P10253 1/20 0.34
GCGR P47871 1/20 0.34
SOAT2 O75908 1/20 0.34
MYC P01106 1/20 0.34
SOAT1 P35610 1/20 0.34
MAP2K3 P46734 1/20 0.34
FABP3 P05413 1/20 0.33
FABP4 P15090 1/20 0.33
POLB P06746 1/20 0.33
RECQL P46063 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
EIF4A3 P38919 1/20 0.32
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32
SLC6A3 Q01959 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19475203 0.85 NLRP3 (0.41) NLRP3GAAFABP3FABP4EIF4A3
SCHEMBL19621872 0.84 CA1 (0.46) NLRP3GAASOAT2MYCSOAT1
SCHEMBL20698736 0.83 NLRP3 (0.40) NLRP3GCGRSOAT2MYCSOAT1
SCHEMBL20681156 0.83 NLRP3 (0.40) NLRP3GCGRSOAT2MYCSOAT1
SCHEMBL19475243 0.80 MTNR1A (0.42) NLRP3GAASOAT2MYCSOAT1
SCHEMBL25112052 0.79 NLRP3 (0.38) NLRP3GCGRSOAT2MYCSOAT1
SCHEMBL18309170 0.78 THRB (0.43)
SCHEMBL22015593 0.78 NLRP3 (0.32) NLRP3GAAGCGREIF4A3
SCHEMBL22014876 0.78 POLB (0.39) NLRP3GAASOAT2MYCSOAT1
SCHEMBL19508138 0.77 NLRP3 (0.36) NLRP3GCGRGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102574-A1 THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-22 WO disclosed